WO2006081152A3 - Estrogen receptor modulators - Google Patents

Estrogen receptor modulators Download PDF

Info

Publication number
WO2006081152A3
WO2006081152A3 PCT/US2006/002148 US2006002148W WO2006081152A3 WO 2006081152 A3 WO2006081152 A3 WO 2006081152A3 US 2006002148 W US2006002148 W US 2006002148W WO 2006081152 A3 WO2006081152 A3 WO 2006081152A3
Authority
WO
WIPO (PCT)
Prior art keywords
disease
estrogen
compounds
receptor modulators
bone
Prior art date
Application number
PCT/US2006/002148
Other languages
French (fr)
Other versions
WO2006081152A2 (en
Inventor
Timothy A Blizzard
Candido Gude
Original Assignee
Merck & Co Inc
Timothy A Blizzard
Candido Gude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Timothy A Blizzard, Candido Gude filed Critical Merck & Co Inc
Publication of WO2006081152A2 publication Critical patent/WO2006081152A2/en
Publication of WO2006081152A3 publication Critical patent/WO2006081152A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Abstract

The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, metastatic bone disease, Paget’s disease, periodontal disease, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restenosis, gynecomastia, vascular smooth muscle cell proliferation, obesity, incontinence, inflammation, inflammatory bowel disease and cancer, in particular of the breast, uterus and prostate.
PCT/US2006/002148 2005-01-24 2006-01-20 Estrogen receptor modulators WO2006081152A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64675405P 2005-01-24 2005-01-24
US60/646,754 2005-01-24

Publications (2)

Publication Number Publication Date
WO2006081152A2 WO2006081152A2 (en) 2006-08-03
WO2006081152A3 true WO2006081152A3 (en) 2007-02-08

Family

ID=36740963

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/002148 WO2006081152A2 (en) 2005-01-24 2006-01-20 Estrogen receptor modulators

Country Status (1)

Country Link
WO (1) WO2006081152A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7273802B2 (en) 2017-08-28 2023-05-15 ゼジアン ジャーチ ディベロップメント ファーマシューティカルズ リミテッド Asymmetric Synthesis of Compounds and Use in Disease Treatment

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
EP2647376A1 (en) 2007-01-22 2013-10-09 Gtx, Inc. Nuclear receptor binding agents
CN102558267A (en) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 Preparation method of testosterone enanthate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218316A (en) * 1963-08-26 1965-11-16 Syntex Corp 10beta-ethynyl-19-norandrostane derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218316A (en) * 1963-08-26 1965-11-16 Syntex Corp 10beta-ethynyl-19-norandrostane derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7273802B2 (en) 2017-08-28 2023-05-15 ゼジアン ジャーチ ディベロップメント ファーマシューティカルズ リミテッド Asymmetric Synthesis of Compounds and Use in Disease Treatment

Also Published As

Publication number Publication date
WO2006081152A2 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
WO2006062876A3 (en) Estrogen receptor modulators
SI1501819T1 (en) Estrogen receptor modulators
TW200631933A (en) Estrogen receptor modulators
EP1257264A4 (en) Estrogen receptor modulators
WO2002091993A3 (en) Estrogen receptor modulators
WO2002041835A3 (en) Estrogen receptor modulators
WO2004073612A3 (en) Estrogen receptor modulators
WO2002032377A3 (en) Estrogen receptor modulators
WO2006081152A3 (en) Estrogen receptor modulators
WO2007062230A3 (en) Nuclear receptor binding agents
WO2004091488A3 (en) Estrogen receptor modulators
WO2008091555A3 (en) Nuclear receptor binding agents
WO2007089291A3 (en) Estrogen receptor modulators
WO2002032373A3 (en) Estrogen receptor modulators
WO2005097141A3 (en) Estrogen receptor modulators
WO2004073610A3 (en) Estrogen receptor modulators
WO2008057309A3 (en) Estrogen receptor modulators
WO2002053522A3 (en) Novel estrogen receptor ligands and methods i
WO2002058639A3 (en) Pyranoflavonoid compounds and their use as estrogen receptor modulators
WO2004026887A3 (en) Estrogen receptor modulators
WO2009059806A3 (en) Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
EA201100226A1 (en) DERIVATIVES OF ESTRATRIEN CONTAINING HETEROCYCLIC BIOISOLAS FOR A-RING PHENOL
WO2008100560A3 (en) Estrogen receptor modulators, associated pharmaceutical compositions and methods of use
DOP2005000224A (en) MODULATORS OF STROGEN RECEIVERS
DOP2002000384A (en) MODULATORS OF ESTROGEN RECEPTORS.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase

Ref document number: 06719112

Country of ref document: EP

Kind code of ref document: A2